Dravet Syndrome is a rare and severe form of epilepsy that typically begins in infancy or early childhood. It is characterized by frequent and prolonged seizures, often triggered by fever or hot temperatures. These seizures can be life-threatening and difficult to control with standard antiepileptic medications.
Children with Dravet Syndrome often experience developmental delays and cognitive impairments, which can impact their overall quality of life. They may also exhibit behavioral and psychiatric issues, such as hyperactivity, sleep disturbances, and social difficulties.
The underlying cause of Dravet Syndrome is usually a genetic mutation that affects the function of sodium channels in the brain. This disruption leads to abnormal electrical activity and the occurrence of seizures.
Managing Dravet Syndrome requires a multidisciplinary approach involving neurologists, geneticists, and other specialists. Treatment focuses on seizure control through a combination of antiepileptic medications, specialized diets, and supportive therapies. Early intervention and individualized care plans are crucial in optimizing outcomes for individuals with Dravet Syndrome.